{"filings":[{"id":67963,"accession_number":"0001516513-26-000017","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2026-05-13T20:04:36+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Doximity Q4 GAAP net income sinks 69%; guides ~4% FY2027 revenue growth; new CFO and President","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["FY2026 revenue $644.9M (+13% YoY); GAAP net income $196.1M (down 12% YoY, margin 30.4%).","Q4 revenue $145.4M (+5% YoY); GAAP net income $19.1M (down 69% YoY, margin 13.1%).","Non-GAAP diluted EPS $0.26 (Q4) vs $0.38 YoY; FY2026 non-GAAP EPS $1.52 vs $1.42.","Guidance: Q1 rev $151-152M; FY2027 rev $664-676M (~4% YoY growth), adj. EBITDA $323-335M.","Appointed Matthew Sonefeldt as CFO (base $400K, $12M RSUs) and Dr. Steven Zatz as President (base $400K, $2.7M RSUs)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93329,"accession_number":"0001516513-26-000014","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2026-04-17T23:59:59+00:00","items":["5.02","7.01"],"status":"ready","headline":"Doximity CFO Anna Bryson resigns; interim CFO continues; guidance reaffirmed","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Anna Bryson's resignation as CFO accepted April 13, 2026, following medical leave since Feb 5, 2026.","Siddharth Sitaram (CAO) serves as interim principal financial and accounting officer effective Feb 3, 2026.","Company reaffirms Q4 and FY2026 guidance originally provided on Feb 5, 2026 earnings release.","CFO search ongoing; update expected on next earnings call."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104874,"accession_number":"0001516513-26-000004","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2026-02-05T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Doximity Q3 revenue up 10% to $185M, guides Q4 $143-144M, authorizes $500M buyback","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $185.1M (+10% YoY); net income $61.6M (33% margin) vs $75.2M (45% margin) YoY.","Adjusted EBITDA $111.4M (60% margin), up 9% YoY; non-GAAP diluted EPS $0.46 vs $0.45.","Q4 guidance: revenue $143-144M, adj EBITDA $63.5-64.5M; FY2026 rev $642.5-643.5M.","Board authorizes new $500M stock repurchase program with no expiration date.","CFO Anna Bryson on temporary medical leave; CAO Siddharth Sitaram named interim principal financial officer."],"consensus_eps_estimate":null,"consensus_eps_actual":0.88,"consensus_revenue_estimate":null,"consensus_revenue_actual":499491000.0,"consensus_period":"2026-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121132,"accession_number":"0001516513-25-000114","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2025-12-30T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Doximity agrees to $31M settlement to resolve securities class action","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Settlement payment of $31 million fully funded by insurance proceeds; no admission of liability.","Parties entered into Agreement of Settlement on Dec 24, 2025, subject to court approval and stockholder notice.","Lawsuit is In re Doximity, Inc. Securities Litigation, No. 5:24-cv-02281 (N.D. Cal.).","Dismissal of all claims against company and named individuals."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":121131,"accession_number":"0001516513-25-000110","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2025-11-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Doximity reports Q2 revenue $168.5M (+23% YoY), adjusted EBITDA $100.8M; raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $168.5M vs $136.8M YoY, up 23%; non-GAAP net income $90.0M (53.4% margin).","Diluted EPS $0.31; non-GAAP diluted EPS $0.45 (vs $0.30). Operating cash flow $93.9M, up 37%.","Record 650K prescribers used workflow tools; AI Scribe and DoxGPT users grew >50% QoQ.","Q3 guidance: rev $180-181M, adj. EBITDA $103-104M. FY2026 updated: rev $640-646M, adj. EBITDA $351-357M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.57,"consensus_revenue_estimate":null,"consensus_revenue_actual":314438000.0,"consensus_period":"2026-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137777,"accession_number":"0001516513-25-000104","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2025-09-02T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Doximity shareholders elect two Class I directors, ratify auditor, approve say-on-pay at 2025 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Jeff Tangney and Kira Wampler elected as Class I directors to serve until 2028 annual meeting.","Ratification of Deloitte & Touche as independent auditor for FY2026 approved with 629,220,010 votes for.","Non-binding advisory vote on named executive officer compensation approved with 589,323,535 votes for.","Shareholder present represented 97.51% of eligible votes, constituting a quorum."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137776,"accession_number":"0001516513-25-000097","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2025-08-15T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Doximity GC Jennifer Chaloemtiarana to step down; John Vaughan named replacement","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jennifer Chaloemtiarana steps down as General Counsel, Corporate Secretary, and Chief Compliance Officer effective August 29, 2025.","John Vaughan will assume all three roles on the same date.","Chaloemtiarana will remain in an advisory capacity through November 17, 2025, then receive post-employment benefits per August 2020 offer letter."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137775,"accession_number":"0001516513-25-000092","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2025-08-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Doximity Q1 revenue $145.9M (+15%), adj. EBITDA $79.8M (+21%), raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $145.9M (+15% YoY); net income $53.3M (36.5% margin); non-GAAP EPS $0.36.","Adjusted EBITDA $79.8M (+21% YoY), margin 54.7%; operating cash flow $62.1M (+51%).","FY2026 guidance raised: revenue $628M-$636M, adj. EBITDA $341M-$349M.","AI suite fastest growing, up 5x YoY; over 630K prescribers used workflow tools.","Acquired Pathway Medical (details in separate release)."],"consensus_eps_estimate":0.2888,"consensus_eps_actual":0.27,"consensus_revenue_estimate":null,"consensus_revenue_actual":145913000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155162,"accession_number":"0001516513-25-000065","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2025-06-13T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Doximity co-founder Dr. Nathan Gross steps down as CSO, stays as advisor","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Dr. Gross transitions from Chief Strategy Officer to advisor effective June 16, 2025.","No cash compensation for advisory role; RSU & option awards continue vesting through September 2025.","Gross co-founded Doximity in 2010 and served as CSO; advisory agreement filed later.","Blog post from CEO Tangney thanks Gross for 15 years; Gross cites 'bittersweet' decision."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":155161,"accession_number":"0001516513-25-000044","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2025-05-15T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Doximity reports Q4 revenue up 17% YoY to $138.3M; guides FY2026 revenue $619-631M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $138.3M (+17% YoY); subscription revenue $131.9M (+17% YoY).","Q4 diluted EPS $0.31; non-GAAP EPS $0.38; adjusted EBITDA $69.7M (50.4% margin).","Fiscal year revenue $570.4M (+20% YoY); net income $223.2M; non-GAAP net income $286.1M.","FY2026 guidance: revenue $619-631M; adjusted EBITDA $333-345M.","Q4 operating cash flow $98.5M (+54% YoY); free cash flow $97.0M (+56% YoY)."],"consensus_eps_estimate":0.4545,"consensus_eps_actual":1.11,"consensus_revenue_estimate":null,"consensus_revenue_actual":570399000.0,"consensus_period":"2025-FY","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173674,"accession_number":"0001516513-25-000009","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2025-02-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Doximity Q3 revenue up 25% YoY to $168.6M; adjusted EBITDA up 39%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net income $75.2M ($0.37 diluted EPS) vs $48.0M YoY; non-GAAP net income $91.4M ($0.45) vs $58.5M.","Revenue $168.6M (+25% YoY); adjusted EBITDA $102.0M, margin 60.5%.","Record engagement: 610,000+ unique providers using clinical workflow tools; AI tools up 60% QoQ.","Q4 guidance: revenue $132.5–$133.5M; adjusted EBITDA $62.5–$63.5M; FY2025 revenue guidance raised to $564.6–$565.6M.","Operating cash flow $65.2M (+30% YoY); free cash flow $63.4M (+30% YoY)."],"consensus_eps_estimate":null,"consensus_eps_actual":0.8,"consensus_revenue_estimate":null,"consensus_revenue_actual":432111000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190635,"accession_number":"0001516513-24-000100","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2024-11-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Doximity Q2 FY2025 revenue $136.8M, up 20% YoY; net income up 44%; raises FY guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $136.8M (+20% YoY); net income $44.2M (+44%); non-GAAP diluted EPS $0.30.","Adjusted EBITDA $76.1M (+41% YoY); margin 55.7% vs 47.7% last year.","Operating cash flow $68.3M (+430% YoY); free cash flow $66.8M (+475% YoY).","Q3 FY25 guidance: revenue $152-153M, adjusted EBITDA $83-84M.","Updated FY25 guidance: revenue $535-540M, adjusted EBITDA $274-279M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.43,"consensus_revenue_estimate":null,"consensus_revenue_actual":263508000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207131,"accession_number":"0001516513-24-000080","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2024-08-30T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Doximity stockholders elect directors, ratify auditor, approve executive compensation at 2024 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders elected Dr. Regina Benjamin and Phoebe Yang as Class III directors with over 543M and 553M votes for, respectively.","Ratification of Deloitte & Touche as independent auditor for FY ending Mar 31, 2025: ~599.8M votes for, 667.5K against.","Non-binding advisory vote on named executive officer compensation passed with ~566.8M votes for, ~8.1M against.","Approximately 82.25% of votes entitled were present, constituting a quorum."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":207130,"accession_number":"0001516513-24-000062","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2024-08-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Doximity Q1 revenue $126.7M (+17% YoY), net income +46%; FY revenue guidance $514-523M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP EPS $0.21 vs $0.13 YoY; non-GAAP EPS $0.28 vs $0.19.","Adjusted EBITDA $65.9M (+42% YoY), margin 52.0% vs 42.9%.","Record 590K unique providers used AI/telehealth/workflow tools in the quarter.","Operating cash flow $41.2M (-28% YoY); free cash flow $39.5M (-29% YoY).","Q2 guidance: revenue $126.5-127.5M, adj. EBITDA $62.5-63.5M."],"consensus_eps_estimate":0.4545,"consensus_eps_actual":0.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":126676000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":224481,"accession_number":"0001516513-24-000019","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2024-05-16T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Doximity beats Q4 estimates; guides FY2025 revenue $506-518M; authorizes $500M buyback","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $118.1M (+6% YoY), subscription $112.7M (+9%); GAAP EPS $0.20, non-GAAP $0.25.","FY2024 revenue $475.4M (+13% YoY); net income $147.6M (+31%); adjusted EBITDA $230.5M (+25%).","FY2025 guidance: revenue $506-518M, adjusted EBITDA $238-250M; Q1 revenue $119.5-120.5M.","Board authorized $500M stock repurchase program (no expiration); all prior programs completed.","Record engagement: over 580,000 unique providers using workflow tools in Q4."],"consensus_eps_estimate":null,"consensus_eps_actual":0.72,"consensus_revenue_estimate":null,"consensus_revenue_actual":475422000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":243789,"accession_number":"0001516513-24-000007","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2024-02-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Doximity Q3 revenue $135.3M (+17% YoY), net income $48.0M; raises FY2024 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $135.3M (up 17% YoY); net income $48.0M (35.4% margin) vs $33.5M (29.0%) YoY.","Adjusted EBITDA $73.3M (+32% YoY), margin 54.2% (prior 48.2%).","Diluted EPS $0.24; non-GAAP diluted EPS $0.29 (vs $0.22).","Q4 guidance: revenue $115.9-$116.9M, adj. EBITDA $50.5-$51.5M.","FY2024 guidance raised: revenue $473.3-$474.3M, adj. EBITDA $224.5-$225.5M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.52,"consensus_revenue_estimate":null,"consensus_revenue_actual":357365000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":261191,"accession_number":"0001516513-23-000082","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2023-11-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Doximity Q2 revenue $113.6M (+11% YoY), adj EBITDA margin 48%; guides FY rev $460-472M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $113.6M, up 11% YoY; net income $30.6M (27% margin); diluted EPS $0.15, non-GAAP $0.22.","Adjusted EBITDA $54.2M (48% margin), up 18% YoY.","Q3 guidance: revenue $127-128M, adj EBITDA $61-62M; FY24 rev $460-472M, adj EBITDA $207-219M.","Operating cash flow $12.9M (down 67% YoY); board authorized $70M stock repurchase."],"consensus_eps_estimate":null,"consensus_eps_actual":0.28,"consensus_revenue_estimate":null,"consensus_revenue_actual":222081000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":278455,"accession_number":"0001516513-23-000066","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2023-08-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Doximity Q1 revenue $108.5M (+20% YoY); workforce reduction of ~100 employees","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $108.5M (+20% YoY); adjusted EBITDA $46.6M (+39% YoY); non-GAAP EPS $0.19 vs $0.14.","Operating cash flow $57.2M (+28%); free cash flow $55.6M (+31%).","Net income $28.4M (26.2% margin); non-GAAP net income $40.6M (37.5% margin).","FY2024 revenue guidance revised to $452-468M; adjusted EBITDA $193-209M.","Workforce reduction of ~100 employees (10%); expects $8-10M restructuring charge in Q2."],"consensus_eps_estimate":null,"consensus_eps_actual":0.13,"consensus_revenue_estimate":null,"consensus_revenue_actual":108469000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":278454,"accession_number":"0001516513-23-000060","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2023-07-28T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Doximity shareholders re-elect directors Spain and Cabral, ratify Deloitte & Touche, favor annual say-on-pay votes","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Kevin Spain re-elected as Class II director: 585.5M votes for, 29.8M withheld.","Timothy Cabral re-elected as Class II director: 593.5M votes for, 21.8M withheld.","Ratification of Deloitte & Touche as auditor for FY2024: 641.1M for, 0.1M against, 37k abstain.","Non-binding advisory vote prefers say-on-pay frequency of one year: 614.1M votes for one year (95.7% of votes cast).","Quorum achieved with 75.10% of votes entitled present at July 26, 2023 Annual Meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":296625,"accession_number":"0001516513-23-000043","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2023-06-06T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Doximity targets $1B revenue by FY2028, adds $200M buyback, unveils AI tools","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Long-term target: >$1B revenue in fiscal 2028; adjusted EBITDA margins of 45%+.","Board authorized $200M share repurchase over next 24 months.","New workflow metric: >500,000 quarterly active workflow providers as of March 31, 2023.","Launched AI chatbot BestDoc.ai, Hold for Me call assistant, and hospital directories at 50+ hospitals.","CEO notes paid enterprise subscriptions now cover over 40% of U.S. physicians."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":296624,"accession_number":"0001516513-23-000028","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2023-05-16T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Doximity Q4 revenue $111M (+18% YoY); FY2024 guidance $500-506M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $111.0M (+18% YoY); net income $30.7M (27.6% margin); adj. EBITDA $48.9M (44.1% margin).","FY2023 revenue $419.1M (+22% YoY); net income $112.8M (26.9% margin); adj. EBITDA $184.0M (43.9% margin).","Q1 FY2024 guidance: revenue $106.5-107.5M, adj. EBITDA $39-40M; FY2024: revenue $500-506M, adj. EBITDA $216-222M.","Appointed Craig Overpeck as SVP Commercial Operations and Ben Greenberg as SVP Commercial Products.","Diluted EPS: Q4 $0.14 (GAAP), $0.20 non-GAAP; FY2023 $0.53 GAAP, $0.73 non-GAAP."],"consensus_eps_estimate":null,"consensus_eps_actual":0.53,"consensus_revenue_estimate":null,"consensus_revenue_actual":419052000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":317047,"accession_number":"0001516513-23-000007","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2023-02-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Doximity Q3 revenue up 18% to $115.3M; cash flow up 85%; FY24 revenue >$500M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $115.3M, +18% YoY.","Net income $33.5M (down from $55.6M YoY); non-GAAP diluted EPS $0.22.","Operating cash flow $48.7M (+78% YoY); free cash flow $47.5M (+85% YoY).","Q4 guidance: revenue $109.6-$110.6M, Adj EBITDA $45.2-$46.2M.","FY2024 preliminary: revenue >$500M, Adj EBITDA margin >=43%."],"consensus_eps_estimate":null,"consensus_eps_actual":0.38,"consensus_revenue_estimate":null,"consensus_revenue_actual":308086000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":335283,"accession_number":"0001516513-22-000082","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2022-11-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Doximity Q2 revenue $102.2M (+29% YoY), beats; net income down; $70M buyback authorized","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $102.2M (+29% YoY); net income $26.3M (26% margin) vs $36.1M (45% margin) year ago.","Non-GAAP EPS $0.17 vs $0.19; adjusted EBITDA $46.0M (45% margin) vs $32.8M (41% margin).","Q3 guidance: revenue $110.7-111.7M, adjusted EBITDA $47.7-48.7M; FY23 revenue $424-432M reiterated.","Board authorized $70M stock repurchase program over next 12 months, via open market or 10b5-1 plans."],"consensus_eps_estimate":null,"consensus_eps_actual":0.23,"consensus_revenue_estimate":null,"consensus_revenue_actual":192824000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":352730,"accession_number":"0001516513-22-000070","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2022-08-04T23:59:59+00:00","items":["2.02","5.02","7.01","9.01"],"status":"ready","headline":"Doximity Q1 FY2023 revenue $90.6M (+25% YoY); appoints Phoebe Yang to board","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $90.6M (+25% YoY); GAAP net income $22.4M (25% margin) vs $26.3M (36%) YoY.","Adjusted EBITDA $33.5M (37% margin); non-GAAP diluted EPS $0.14 vs $0.11 YoY.","Operating cash flow $44.8M (+35%); free cash flow $42.6M (+32%).","Guidance: Q2 revenue $99.5-100.5M, adj. EBITDA $40-41M; FY2023 revenue $424-432M, adj. EBITDA $178-186M.","Appointed Phoebe L. Yang (GM, AWS Healthcare) to board, replacing Gilbert Kliman; initial RSU grant $350K."],"consensus_eps_estimate":null,"consensus_eps_actual":0.1,"consensus_revenue_estimate":null,"consensus_revenue_actual":90639000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":352729,"accession_number":"0001516513-22-000065","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2022-07-29T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Doximity shareholders re-elect Tangney and Wampler as directors; ratify Deloitte","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Jeffrey Tangney re-elected with 874,523,998 votes for, 10,203,377 withheld; Kira Wampler re-elected with 867,045,650 for, 17,681,725 withheld.","Ratification of Deloitte & Touche as independent auditor for FY ending March 31, 2023 passed with 910,928,660 for, 118,905 against, 109,967 abstain.","Quorum of 911,157,532 votes (96.86% of eligible) present at the 2022 Annual Meeting held July 27, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":370309,"accession_number":"0001516513-22-000029","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2022-05-17T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Doximity Q4 revenue $93.7M (+40% YoY), FY2022 rev $343.5M (+66%); guides FY23 rev $454-458M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $93.7M (up 40% YoY); net income $36.7M (39% margin); adjusted EBITDA $39.4M (42% margin).","FY2022 revenue $343.5M (up 66% YoY); net income $154.8M (45% margin); adj. EBITDA $150.3M (44% margin).","Q1 FY2023 revenue guidance $88.6-89.6M; adjusted EBITDA $28.6-29.6M.","FY2023 revenue guidance $454-458M; adjusted EBITDA $192-196M.","Board authorized $70M stock repurchase program; acquired Amion scheduling."],"consensus_eps_estimate":null,"consensus_eps_actual":0.7,"consensus_revenue_estimate":null,"consensus_revenue_actual":343548000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":389417,"accession_number":"0001516513-22-000007","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2022-02-08T23:59:59+00:00","items":["2.02","5.02","9.01"],"status":"ready","headline":"Doximity Q3 revenue $97.9M (+67% YoY), net margin 57%, guides FY23 rev ~$450M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $97.9M (+67% YoY); net income $55.6M (57% margin); non-GAAP diluted EPS $0.29.","Adjusted EBITDA $47.0M (+119% YoY); margin 48% vs 37% prior year.","Q4 guidance: rev $89-90M, adj EBITDA $34-35M; FY23 prelim: rev ~$450M (33% growth excl. Amion), adj EBITDA margin ≥40%.","Agreed to acquire Amion (powers ~200K physician schedules); CCO Joseph Kleine retires to advisor role."],"consensus_eps_estimate":null,"consensus_eps_actual":0.53,"consensus_revenue_estimate":null,"consensus_revenue_actual":249895000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":407356,"accession_number":"0001516513-21-000025","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2021-11-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Doximity Q2 FY2022 revenue $79.4M (+76% YoY); net income $36.1M; lock-up expiry Nov 12","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $79.4M, up 76% YoY; net income $36.1M (45% margin); non-GAAP net income $41.6M (52% margin).","Adjusted EBITDA $32.8M (41% margin); non-GAAP diluted EPS $0.19 vs $0.02 YoY.","Net revenue retention rate 173% trailing 12 months; telehealth active providers over 330,000.","Q3 FY2022 guidance: revenue $85.8-86.8M; adjusted EBITDA $32.0-33.0M.","Lock-up expiry on Nov 12, 2021; certain shares become eligible for public sale."],"consensus_eps_estimate":null,"consensus_eps_actual":0.27,"consensus_revenue_estimate":null,"consensus_revenue_actual":152019000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":426358,"accession_number":"0001516513-21-000006","cik":1516513,"company_name":"Doximity, Inc.","ticker":"DOCS","form_type":"8-K","filed_at":"2021-08-10T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Doximity Q1 revenue $72.7M (+100% YoY); net income margin 36%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $72.7M, up 100% YoY; net income $26.3M (36% margin) vs $1.5M a year ago.","Adjusted EBITDA $31.2M (43% margin) vs $3.9M (11%) a year ago.","Non-GAAP diluted EPS $0.11; trailing 12-month net revenue retention 167%.","Q2 guidance: revenue $73-74M, adj. EBITDA $26.4-27.4M.","FY2022 guidance: revenue $296.5-299.5M, adj. EBITDA $106-109M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":72669000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":3850370936.8854876,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}